Detailed information for compound 1210038

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 487.377 | Formula: C21H18F5N3O5
  • H donors: 3 H acceptors: 4 LogP: 3.99 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: Cc1ccc(o1)[C@@H](C(C(F)(F)F)(F)F)NC1=C(C(=O)C1=O)Nc1cccc(c1O)C(=O)N(C)C
  • InChi: 1S/C21H18F5N3O5/c1-9-7-8-12(34-9)18(20(22,23)21(24,25)26)28-14-13(16(31)17(14)32)27-11-6-4-5-10(15(11)30)19(33)29(2)3/h4-8,18,27-28,30H,1-3H3/t18-/m0/s1
  • InChiKey: IACZVCYFISPAOZ-SFHVURJKSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens chemokine (C-X-C motif) receptor 1 Starlite/ChEMBL References
Homo sapiens chemokine (C-X-C motif) receptor 2 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Mycobacterium ulcerans fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE 0.0036 0 0.5
Plasmodium vivax hypothetical protein, conserved 0.0036 0 0.5
Mycobacterium ulcerans esterase/lipase LipP 0.0036 0 0.5
Mycobacterium ulcerans hypothetical protein 0.0036 0 0.5
Schistosoma mansoni hypothetical protein 0.0093 0.2958 1
Echinococcus granulosus Cystatin B Stefin B 0.0093 0.2958 1
Trypanosoma cruzi hypothetical protein, conserved 0.0036 0 0.5
Schistosoma mansoni hypothetical protein 0.0093 0.2958 1
Loa Loa (eye worm) cystatin 0.0093 0.2958 1
Echinococcus granulosus proteinase inhibitor I25 cystatin 0.0093 0.2958 1
Leishmania major hypothetical protein, conserved 0.0036 0 0.5
Trypanosoma cruzi hypothetical protein, conserved 0.0036 0 0.5
Onchocerca volvulus 0.0093 0.2958 1
Echinococcus multilocularis proteinase inhibitor I25, cystatin 0.0093 0.2958 1
Schistosoma mansoni cystatin B 0.0093 0.2958 1
Loa Loa (eye worm) hypothetical protein 0.0093 0.2958 1
Brugia malayi cystatin 0.0093 0.2958 1
Onchocerca volvulus 0.0093 0.2958 1
Mycobacterium leprae conserved hypothetical protein 0.0036 0 0.5
Mycobacterium ulcerans lipase LipD 0.0036 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0093 0.2958 1
Loa Loa (eye worm) cystatin-type cysteine proteinase inhibitor CPI-1 0.0093 0.2958 1
Mycobacterium ulcerans beta-lactamase 0.0036 0 0.5
Onchocerca volvulus 0.0093 0.2958 1
Brugia malayi cathepsin F-like cysteine proteinase 0.0093 0.2958 1
Trypanosoma brucei hypothetical protein, conserved 0.0036 0 0.5
Onchocerca volvulus 0.0093 0.2958 1
Loa Loa (eye worm) cysteine protease inhibitor 0.0093 0.2958 1
Mycobacterium leprae Probable lipase LipE 0.0036 0 0.5
Brugia malayi cystatin 0.0093 0.2958 1
Trichomonas vaginalis Clan IH, family I25, phytocystatin-like peptidase inhibitor 0.0093 0.2958 1
Onchocerca volvulus 0.0093 0.2958 1
Toxoplasma gondii ABC1 family protein 0.0036 0 0.5
Onchocerca volvulus 0.0093 0.2958 1
Echinococcus multilocularis Cystatin B (Stefin B) 0.0093 0.2958 1
Brugia malayi cystatin-type cysteine proteinase inhibitor CPI-2, putative 0.0093 0.2958 1

Activities

Activity type Activity value Assay description Source Reference
Ki (binding) = 4 nM Binding affinity to CXCR2 ChEMBL. 19196511
Ki (binding) = 10 nM Binding affinity to CXCR1 ChEMBL. 19196511

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.